Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 235
Titolo Data di pubblicazione Autore(i) File
Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma 2007 Matta GM; Battaglio S; Dibello C; Napoli P; Baldi C; Ciccone G; Coscia M; Boccadoro M; Massaia M
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells 2007 Marta Coscia; Silvia Peola; Giorgia Matta; Francesca Pantaleoni; Myriam Foglietta; Daniela Angelini; Sabina Chiaretti; Chiara Riganti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Robin Foà; Luca Battistini; Mario Boccadoro; Jean Jacques Fournie; Massimo Massaia
Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia 2007 Pantaleoni F; Coscia M; Bussolati B; Deambrosis I; Peola S; Rigoni M; Boccadoro M; Camussi G; Massaia M
Effective anti-tumor immunomodulatory properties of zoledronic acid 2007 Coscia M; Quaglino E; Pantaleoni F; Curcio C; Rigoni M; Forni G; Massaia M
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) 2008 M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia
CEP-18770: a novel orally-active proteasome inhibitor with a tumor-selective pharmacological profile competitive with bortezomib 2008 Piva R; Ruggeri B; Williams M;Costa G;Tamagno I; Ferrero D; Giai V; Coscia M; Peola S; Massaia M;Pezzoni G; Allievi C; Pescalli N; Cassin M; di Giovine S; Nicoli P;de Feudis P; Strepponi I; Roato I; Ferracini R; Bussolati B; Camussi G; Jones-Bolin S; Hunter K; Zhao H; Neri A; Palumbo A; Berkers C; Ovaa H; Bernareggi A; Inghirami G
Murine {beta}-defensin 2 promotes TLR-4/MyD88-mediated and NF-{kappa}B-dependent atypical death of APCs via activation of TNFR 2008 BIRAGYN A; COSCIA M; NAGASHIMA K; SANFORD M; YOUNG HA; OLKHANUD P
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT 2009 Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis 2009 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method 2009 Mariani S; Hwang SY; Foglietta M; Bonello L; Vitale C; Coscia M; Fiore F; Bruno B; Massaia M.
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 2009 Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M.
THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES 2009 M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 2010 Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. 2010 Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL 2010 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
Unmutated IGHV1-69/D3-16/J3 Stereotyped HCDR3 Rearrangements (Subset 6) Are Associated with Indolent Disease Course and Have Outcome Independent of Mutational Status In Early Stage CLL (Rai 0) 2010 Francesco Forconi; Emanuele Cencini; Davide Rossi; Riccardo Bomben; Elisa Sozzi; Marta Coscia; Massimo Massaia; Silvio Veronese; Alessandra Tedeschi; Marco Montillo; Rita Fazzi; Mario Petrini; Stefania Ciolli; Alberto Bosi; Roberto Dottori; Maria Teresa Pirrotta; Alessandra Caremani; Giovanni Del Poeta; Ilaria Del Giudice; Simona Santangelo; Luca Laurenti; Dimitar G Efremov; Livio Trentin; Luca Arcaini; Ester Orlandi; Francesco Bertoni; Rossana Maffei; Robin Foà; Roberto Marasca; Valter Gattei; Gianluca Gaidano; Francesco Lauria
IGHV1-69/D3-16/J3 SUBSET 6 IS ASSOCIATED WITH INDOLENT DISEASE COURSE OF EARLY STAGE CLL (RAI 0) INDEPENDENT OF UNMUTATED STATUS 2010 F Forconi ;E Cencini ;D Rossi ;E Sozzi ;R Bomben ;R Marasca ;M Coscia ;M Massaia ;S Veronese ;A Tedeschi ;M Montillo ;R Fazzi ;M Petrini ;S Ciolli ;A Bosi ;R Dottori ;M Pirrotta ;A Caremani ;G Del Poeta ;I Del Giudice ;S Santangelo ;L Laurenti ;D Efremov ;L Trentin ;F Bertoni ;V Gattei ;G Gaidano ;F Lauria
Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway 2010 Coscia M; Quaglino E; Iezzi M; Curcio C; Pantaleoni F; Riganti C; Holen I; Mönkkönen H; Boccadoro M; Forni G; Musiani P; Bosia A; Cavallo F; Massaia M
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals 2010 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 2011 Genuardi E; Ruggeri M; Drandi D; Caltagirone S; Mastrocola R; Bernocco E; Lobetti Bodoni C; Boi M; Monitillo L; Mantoan B; Mantella E; Isaia G; Bergui L; Coscia M; Boccadoro M; Massaia M; Omedè P; Ladetto M
Mostrati risultati da 21 a 40 di 235
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile